CoChat

The prognostic significance of sarcopenia in patients treated with definitive radiotherapy: A systematic review

Vickers, Alexander J., McSweeney, Dónal M., Choudhury, Ananya, Weaver, Jamie, Price, Gareth, McWilliam, Alan · 2025 · Radiotherapy and Oncology
Cited by 15

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2024.110663

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 99

  1. Shachar, 2016, Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review, Eur J Can, 57, 58, 10.1016/j.ejca.2015.12.030 · DOI · Paper page
  2. Keller, 2013, Strength and muscle mass loss with aging process. Age and strength loss, Muscles Ligaments Tendons J, 3, 346, 10.32098/mltj.04.2013.17 · DOI · Paper page
  3. Joseph, 2005, Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk, Mol Aspects Med, 26, 181, 10.1016/j.mam.2005.01.004 · DOI
  4. Bahat, 2016, Sarcopenia and the cardiometabolic syndrome: a narrative review, Eur Geriatric Med, 7, 220, 10.1016/j.eurger.2015.12.012 · DOI
  5. Bone, 2017, Sarcopenia and frailty in chronic respiratory disease, Chron Respir Dis, 14, 85, 10.1177/1479972316679664 · DOI · Paper page
  6. Beaudart, 2017, Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia, J Cachexia Sarcopenia Muscle, 8, 238, 10.1002/jcsm.12149 · DOI · Paper page
  7. Landi, 2013, Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study, Age Ageing, 42, 203, 10.1093/ageing/afs194 · DOI · Paper page
  8. Sousa, 2016, Sarcopenia and length of hospital stay, Eur J Clin Nutr, 70, 595, 10.1038/ejcn.2015.207 · DOI · Paper page
  9. Antunes, 2017, Sarcopenia and hospitalisation costs in older adults: a cross-sectional study, Nutr Diet, 74, 46, 10.1111/1747-0080.12287 · DOI · Paper page
  10. Beaudart, 2016, Sarcopenia in daily practice: assessment and management, BMC Geriatr, 16, 170, 10.1186/s12877-016-0349-4 · DOI · Paper page
  11. Chu, 2015, Fully automatic localization and segmentation of 3D vertebral bodies from CT/MR images via a learning-based method, PLoS One, 10, 10.1371/journal.pone.0143327 · DOI
  12. Bozzetti, 2017, Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy, Ann Oncol, 28, 2107, 10.1093/annonc/mdx271 · DOI · Paper page
  13. Trejo-Avila, 2021, Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis, Int J Colorectal Dis, 36, 1077, 10.1007/s00384-021-03839-4 · DOI · Paper page
  14. Baskar, 2012, Cancer and radiation therapy: current advances and future directions, Int J Med Sci, 9, 193, 10.7150/ijms.3635 · DOI · Paper page
  15. Di Maggio, 2015, Portrait of inflammatory response to ionizing radiation treatment, J Inflamm, 12, 14, 10.1186/s12950-015-0058-3 · DOI · Paper page
  16. Cho, 2018, Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy, Front Oncol, 8, 457, 10.3389/fonc.2018.00457 · DOI
  17. Nagpal, 2021, Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: an Indian tertiary care hospital experience, Oral Oncol, 121, 10.1016/j.oraloncology.2021.105483 · DOI
  18. Shodo, 2021, Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy, Eur Arch Otorhinolaryngol, 278, 2001, 10.1007/s00405-020-06273-4 · DOI
  19. Bergamaschi, 2023, Prognostic impact of sarcopenia's occurrence during radiotherapy in oropharyngeal cancer patients, Cancers (Basel), 15, 10.3390/cancers15030723 · DOI · Paper page
  20. Wendrich, 2017, Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer, Oral Oncol, 71, 26, 10.1016/j.oraloncology.2017.05.012 · DOI · Paper page
  21. Pai, 2018, Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan, Cancer Med, 7, 1630, 10.1002/cam4.1365 · DOI
  22. Hua, 2021, Modeling sarcopenia to predict survival for patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy, Front Oncol, 11, 10.3389/fonc.2021.625534 · doi:10.3389/fonc.2021.625534
  23. Sato, 2018, Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy, In Vivo, 32, 603
  24. Ma, 2019, Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer, Front Oncol, 9, 366, 10.3389/fonc.2019.00366 · DOI
  25. Mallet, 2020, Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer, Radiat Oncol, 15, 116, 10.1186/s13014-020-01545-z · DOI
  26. Liang, 2021, Prognostic value of sarcopenia and systemic inflammation markers in patients undergoing definitive radiotherapy for esophageal cancer, Cancer Manag Res, 13, 181, 10.2147/CMAR.S288522 · DOI
  27. Qian, 2022, Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy, BMC Gastroenterol, 22, 211, 10.1186/s12876-022-02296-9 · DOI
  28. McSweeney, 2023, Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapy, Radiother Oncol, 186, 10.1016/j.radonc.2023.109764 · DOI
  29. Shiba, 2018, No Deterioration in clinical outcomes of carbon ion radiotherapy for sarcopenia patients with hepatocellular carcinoma, Anticancer Res, 38, 3579, 10.21873/anticanres.12631 · doi:10.21873/anticanres.12631
  30. Jin, 2018, Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy, J Gastrointest Oncol, 9, 24, 10.21037/jgo.2017.09.13 · DOI
  31. Cho, 2021, Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy, Tumori, 107, 247, 10.1177/0300891620937795 · DOI
  32. Martin, 2020, Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma, Front Oncol, 10, 1576, 10.3389/fonc.2020.01576 · DOI
  33. Katsui, 2021, Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis, Sci Rep, 11, 11882, 10.1038/s41598-021-91449-z · DOI
  34. Kiss, 2019, Early skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival, Support Care Can, 27, 2657, 10.1007/s00520-018-4563-9 · DOI
  35. Matsuo, 2018, Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer, J Geriatr Oncol, 9, 589, 10.1016/j.jgo.2018.05.003 · DOI
  36. Mitsuyoshi, 2018, Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy, J Radiat Res, 59, 50, 10.1093/jrr/rrx060 · DOI
  37. Stangl-Kremser, 2019, Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder, Urol Oncol, 37, 372, 10.1016/j.urolonc.2018.11.001 · DOI
  38. Ferini, 2021, Curative Radiotherapy in Elderly Patients With Muscle Invasive Bladder Cancer: The Prognostic Role of Sarcopenia, In Vivo, 35, 571, 10.21873/invivo.12293 · DOI
  39. McDonald, 2017, CT measures of bone mineral density and muscle mass can be used to predict noncancer death in men with prostate cancer, Radiology, 282, 475, 10.1148/radiol.2016160626 · DOI
  40. Matsuoka, 2019, Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy, Anticancer Res, 39, 933, 10.21873/anticanres.13196 · DOI
  41. Lee, 2018, Skeletal muscle loss is an imaging biomarker of outcome after definitive chemoradiotherapy for locally advanced cervical cancer, Clin Can Res, 24, 5028, 10.1158/1078-0432.CCR-18-0788 · DOI
  42. Klinder, 2009, Automated model-based vertebra detection, identification, and segmentation in CT images, Med Image Anal, 13, 471, 10.1016/j.media.2009.02.004 · DOI · Paper page
  43. Forsberg, 2017, Detection and labeling of vertebrae in MR images using deep learning with clinical annotations as training data, J Digit Imaging, 30, 406, 10.1007/s10278-017-9945-x · DOI
  44. Mourtzakis, 2008, A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl Physiol Nutr Metab, 33, 997, 10.1139/H08-075 · DOI · Paper page
  45. Anyene, 2022, Body composition from single versus multi-slice abdominal computed tomography: concordance and associations with colorectal cancer survival, J Cachexia Sarcopenia Muscle, 13, 2974, 10.1002/jcsm.13080 · DOI
  46. Panthofer, 2019, Derivation and validation of thoracic sarcopenia assessment in patients undergoing thoracic endovascular aortic repair, J Vasc Surg, 69, 1379, 10.1016/j.jvs.2018.08.180 · DOI
  47. Swartz, 2016, Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients, Oral Oncol, 62, 28, 10.1016/j.oraloncology.2016.09.006 · DOI · Paper page
  48. Chang, 2021, Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer, PLoS One, 16
  49. Yoon, 2021, Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer, PLoS One, 16, 10.1371/journal.pone.0254844 · DOI
  50. Gu, 2018, Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis, Clin Mol Hepatol, 24, 319, 10.3350/cmh.2017.0077 · DOI · Paper page
  51. Rutten, 2017, Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer, J Cachexia Sarcopenia Muscle, 8, 630, 10.1002/jcsm.12180 · DOI · Paper page
  52. Sebro, 2016, Assessment of trunk muscle density using CT and its association with degenerative disc and facet joint disease of the lumbar spine, Skeletal Radiol, 45, 1221, 10.1007/s00256-016-2405-8 · DOI
  53. Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
  54. Martin, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722 · DOI · Paper page
  55. Silva, 2010, Ethnicity-related skeletal muscle differences across the lifespan, Am J Hum Biol, 22, 76, 10.1002/ajhb.20956 · DOI · Paper page
  56. Heagerty, 2000, Time-dependent ROC curves for censored survival data and a diagnostic marker, Biometrics, 56, 337, 10.1111/j.0006-341X.2000.00337.x · DOI · Paper page
  57. van Vledder, 2012, Body composition and outcome in patients undergoing resection of colorectal liver metastases19, Br J Surg, 99, 550, 10.1002/bjs.7823 · DOI · Paper page
  58. Fujiwara, 2015, Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma, J Hepatol, 63, 131, 10.1016/j.jhep.2015.02.031 · DOI · Paper page
  59. Janssen, 2000, Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr, J Appl Physiol, 89, 81, 10.1152/jappl.2000.89.1.81 · DOI · Paper page
  60. Erul, 2023, Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives, Eur Arch Otorhinolaryngol, 280, 3541, 10.1007/s00405-023-08014-9 · DOI
  61. de Bree, 2022, Sarcopenia and its impact in head and neck cancer treatment, Curr Opin Otolaryngol Head Neck Surg, 30, 87, 10.1097/MOO.0000000000000792 · DOI
  62. Findlay, 2020, The association between computed tomography-defined sarcopenia and outcomes in adult patients undergoing radiotherapy of curative intent for headand neck cancer: a systematic review, J Acad Nutr Diet, 120, 10.1016/j.jand.2020.03.021 · DOI
  63. Hua, 2019, When the loss costs too much: a systematic review and meta-analysis of sarcopenia in head and neck cancer, Front Oncol, 9, 1561, 10.3389/fonc.2019.01561 · DOI
  64. Medici, 2022, Impact and treatment of sarcopenia in patients undergoing radiotherapy: a multidisciplinary, AMSTAR-2 compliant review of systematic reviews and metanalyses, Front Oncol, 12, 10.3389/fonc.2022.887156 · DOI
  65. Paireder, 2017, Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer, Eur J Surg Oncol, 43, 478, 10.1016/j.ejso.2016.11.015 · DOI
  66. Grotenhuis, 2016, Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer, World J Surg, 40, 2698, 10.1007/s00268-016-3603-1 · DOI · Paper page
  67. Jogiat, 2022, Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 2630, 10.1002/jcsm.13082 · DOI
  68. Harimoto, 2013, Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma, Br J Surg, 100, 1523, 10.1002/bjs.9258 · DOI · Paper page
  69. Mintziras, 2018, Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis, Int J Surg, 59, 19, 10.1016/j.ijsu.2018.09.014 · DOI · Paper page
  70. Buentzel, 2019, Sarcopenia as prognostic factor in lung cancer patients: a systematic review and meta-analysis, Anticancer Res, 39, 4603, 10.21873/anticanres.13640 · DOI
  71. Yang, 2019, Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis, Chest, 156, 101, 10.1016/j.chest.2019.04.115 · DOI · Paper page
  72. Bingmer, 2020, Sarcopenia is associated with worse overall survival in patients with anal squamous cell cancer, J Surg Oncol, 121, 1148, 10.1002/jso.25887 · DOI
  73. De Nardi, 2022, Relation between skeletal muscle volume and prognosis in rectal cancer patients undergoing neoadjuvant therapy, World J Gastrointest Oncol, 14, 423, 10.4251/wjgo.v14.i2.423 · DOI
  74. Vergara-Fernandez, 2020, Sarcopenia in patients with colorectal cancer: a comprehensive review, World J Clin Cases, 8, 1188, 10.12998/wjcc.v8.i7.1188 · DOI
  75. Psutka, 2014, Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality, Cancer, 120, 2910, 10.1002/cncr.28798 · DOI · Paper page
  76. Catikkas, 2022, Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes, Aging Clin Exp Res, 34, 1747, 10.1007/s40520-022-02085-0 · DOI
  77. Chargi, 2019, Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer, Eur Arch Otorhinolaryngol, 276, 1475, 10.1007/s00405-019-05361-4 · DOI
  78. Jahrreiss, 2021, The prognostic value of sarcopenia in patients with prostate cancer: a systematic review, Curr Opin Urol, 31, 10.1097/MOU.0000000000000885 · DOI
  79. Zakaria, 2020, Sarcopenia predicts overall survival in patients with lung, breast, prostate, or myeloma spine metastases undergoing stereotactic body radiation therapy (SBRT), Independent of Histology Neurosurgery, 86, 705
  80. Gadducci, 2021, The prognostic relevance of computed tomography-assessed skeletal muscle index and skeletal muscle radiation attenuation in patients with gynecological cancer, Anticancer Res, 41, 9, 10.21873/anticanres.14747 · DOI
  81. Xiao, 2024, Impact of skeletal muscle loss and sarcopenia on outcomes of locally advanced esophageal cancer during neoadjuvant chemoradiation, Ann Surg Oncol
  82. Abe, 2022, Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study, Int J Clin Oncol, 27, 141, 10.1007/s10147-021-02062-z · DOI
  83. Ming, 2023, Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy, Front Nutrit, 10
  84. Grossberg, 2021, Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy, Radiother Oncol, 159, 21, 10.1016/j.radonc.2021.03.005 · DOI
  85. Grossberg, 2016, Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma, JAMA Oncol, 2, 782, 10.1001/jamaoncol.2015.6339 · DOI · Paper page
  86. Findlay, 2020, Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost, J Hum Nutr Diet, 33, 811, 10.1111/jhn.12788 · DOI
  87. Yoon, 2020, Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer, Cancers (Basel), 12, 10.3390/cancers12040925 · DOI
  88. Sanchez A, Perni S, Kim P, Horowitz DP. Surgical resection after neoadjuvant chemoradiation in patients with sarcopenia and pancreatic cancer. Int J Radiat Oncol Biol Phys 2019;105(1, Supplement):E244-E5. · doi:10.1016/j.ijrobp.2019.06.1927
  89. Aleixo, 2020, Myosteatosis and prognosis in cancer: systematic review and meta-analysis, Crit Rev Oncol Hematol, 145, 10.1016/j.critrevonc.2019.102839 · DOI · Paper page
  90. Stenholm, 2008, Sarcopenic obesity: definition, cause and consequences, Curr Opin Clin Nutr Metab Care, 11, 693, 10.1097/MCO.0b013e328312c37d · DOI · Paper page
  91. Huo, 2024, Grip-Strength-Lean-Mass Index (GSLMI) as a valuable tool for sarcopenia diagnosis and survival prognosis in cancer patients: a nationwide multicenter cohort study, J Nutr Health Aging, 29
  92. Davis, 2019, Sarcopenia associated with chemotherapy and targeted agents for cancer therapy, Ann Palliat Med, 8, 86, 10.21037/apm.2018.08.02 · DOI · Paper page
  93. Greten, 2019, Inflammation and cancer: triggers, mechanisms, and consequences, Immunity, 51, 27, 10.1016/j.immuni.2019.06.025 · DOI · Paper page
  94. Capitão, 2022, Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review, Support Care Cancer, 30, 3007, 10.1007/s00520-021-06633-8 · DOI
  95. Prokopidis, 2022, Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 1642, 10.1002/jcsm.12976 · DOI · Paper page
  96. Read, 2007, Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial, Support Care Cancer, 15, 301, 10.1007/s00520-006-0153-3 · DOI
  97. Wright, 2018, A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women, J Cachexia Sarcopenia Muscle, 9, 482, 10.1002/jcsm.12295 · DOI · Paper page
  98. Adams, 2016, Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial, Breast Cancer Res Treat, 158, 497, 10.1007/s10549-016-3900-2 · DOI · Paper page
  99. Sharp, 2014, The effects of a myostatin inhibitor on lean body mass, strength, and power in resistance trained males, J Int Soc Sports Nutr, 11, P42, 10.1186/1550-2783-11-S1-P42 · DOI

Metadata

Authors
Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., Price, G., & McWilliam, A.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2025-02
Volume
203
Pages
110663
ISSN
0167-8140
Cited by
15
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.